Home › Funds › Ishara Investments LP › ZNTL
Ishara Investments LP position in ZNTL
ZENTALIS PHARMACEUTICALS INC · Health Care
Ishara Investments LP reported holding 1,080,000 shares of ZNTL (ZENTALIS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$3.0M, representing 2.52% of its reported portfolio and ranking #17 among its reported holdings. Ishara Investments LP has disclosed ZNTL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Ishara Investments LP's ZNTL position evolved
Ishara Investments LP first disclosed a stake in ZNTL in Q4 2025 at 1,320,000 shares (US$1.8M). The position peaked in Q2 2026 at 1,025,000 shares, worth US$5.0M. Across 4 filings, Ishara Investments LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,080,000 shares valued at US$3.0M — an increase of 55,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.32M | $1.78M | New |
| Q1 2026 | 1.23M | $2.88M | Reduce |
| Q2 2026 | 1.02M | $4.97M | Reduce |
| Q3 2026 | 1.08M | $2.99M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZNTL and 13F data
ZNTL (ZENTALIS PHARMACEUTICALS INC) is a Health Care company. 26 other funds we track also report a position in ZNTL — the largest reported positions include 5AM Venture Management, LLC (US$19.1M), Opaleye Management Inc. (US$6.9M), Patient Square Capital LP (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZNTL
- 5AM Venture Management, LLC 3.95M sh · $19.15M · Q2 2026
- Opaleye Management Inc. 1.41M sh · $6.85M · Q2 2026
- Patient Square Capital LP 2.01M sh · $5.56M · Q3 2026
- Decheng Capital LLC 1.32M sh · $3.67M · Q3 2026
- PFIZER INC 953.83K sh · $2.58M · Q3 2026
- Squadron Capital Management LLC 426.00K sh · $2.07M · Q2 2026
More on Ishara Investments LP
FAQ
How long has Ishara Investments LP held ZNTL?
Ishara Investments LP has disclosed ZNTL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Ishara Investments LP's current position in ZNTL?
As of Q3 2026, Ishara Investments LP holds 1.08M shares of ZNTL (ZENTALIS PHARMACEUTICALS INC), valued at $2.99M, representing 2.52% of its reported portfolio and ranking #17.
Has Ishara Investments LP been buying or selling ZNTL?
In the latest 13F filing (Q3 2026), Ishara Investments LP increased its position in ZNTL. The position peaked in Q2 2026 at 1.02M shares.
Which other funds hold ZNTL?
Other major institutional holders of ZNTL include 5AM Venture Management, LLC, Opaleye Management Inc., Patient Square Capital LP, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.